A Phase 1b/2, Multi-center, Single Arm Study to Assess the Safety and Efficacy of Neoantigen Synthetic Long Peptide Vaccines in Patients With Local Or Metastatic Solid Tumors
Clinical trial NCT05741242 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT05741242
- Sponsor
- Jaime Leandro Foundation for Therapeutic Cancer Vaccines
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-30
- Primary completion
- 2027-01-01
- Enrollment
- 136
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.